Coherus Oncology

1. Casdozokitug Ph2 topline2H 2026Casdozokitug Ph2 topline, 2H 2026, thesis-defining
2. Tagmokitug ESCC Ph1 interim2H 2026Tagmokitug ESCC Ph1 interim, 2H 2026, notable
3. Tagmokitug MSS Ph1 interim2H 2026Tagmokitug MSS Ph1 interim, 2H 2026, notable
4. Tagmokitug + pasritamig Ph1 startFall 2026Tagmokitug + pasritamig Ph1 start, Fall 2026, routine
5. UDENYCA corporate updateMar 31, 2027UDENYCA corporate update, Mar 31, 2027, routine
6. Term B Loan corporate updateSep 1 – Apr 30, 2028Term B Loan corporate update, Sep 1 – Apr 30, 2028, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.